Eurofins Will Be Included in the CAC 40 Index From September 17
10 Septembre 2021 - 7:15AM
Business Wire
Eurofins Scientific, a global leader in food, environment,
pharmaceutical and cosmetic product testing, is very pleased to
announce that the Steering Committee of the Euronext Indices has
made the decision on 9 September 2021 to include Eurofins
Scientific in the CAC 40 Index.
At 9 September 2021, the Group’s market capitalisation stood at
more than €23.5 billion. Based on 9 September 2021 share prices
this would put Eurofins in the 29th position in the CAC 40 index
ranked by market capitalisation. Eurofins Scientific's inclusion in
the CAC 40 Index will be effective on Friday 17 September 2021,
after market close.
Eurofins joins the CAC 40 Index, consisting of large and very
large groups, many of which are over 100 years old (on average
around 102 years old), only 34 years after its creation in
1987.
Eurofins’ Founder and CEO, Gilles Martin commented: “We are
delighted by the decision to include Eurofins in the CAC 40. It is
a significant milestone in the history of the group. Since the
foundation of its first company in 1987 in Nantes, France with four
employees and listing in Paris in 1997, Eurofins Scientific has
been one of the fastest growing, listed European groups increasing
revenues by 32% (in compound average) since 1988 through organic
growth and acquisitions and its share price by more than 30% each
year (in compound average) since its IPO in October 1997.
Today Eurofins is a global leader in many of its markets and
continues its mission to contribute to a safer and healthier world
by providing our customers with innovative and high quality
laboratory, research and advisory services, whilst creating
opportunities for our employees and generating sustainable
shareholder value. This mission has never been more critical than
today, where the Group has been agile and innovative, rapidly
developing new testing solutions to fight the spread of COVID-19
and its variants.
I would like to take this opportunity to once again thank all of
our 55,000 employees and leaders worldwide, whose dedication,
innovation and entrepreneurial spirit and focus on service to our
customers have been and remain instrumental for the continued
success of the group, as well as the clients, suppliers and public
and private partners of all Eurofins’ companies around the world
for their trust and continued support.”
Eurofins Scientific’s shares are also part of the following
indices on Euronext Paris: EURONEXT 100, SBF 120, SBF TOP 80 EW,
CAC ALL SHARES, CAC ALL-TRADABLE, CAC HEALTH CARE, CAC L60 RI SW,
CAC LARGE 60, CAC LARGE 60 EW, and EN H C EQ & SER EW; on
Euronext Amsterdam: EN CORE E100 EW, EN EUR N100 EW, EN EUROZONE
150 EW, EN EUROPE 500, EN EUROZONE 300, and EN EZ L&M 60 EW ;
and also MSCI Europe, STOXX Europe 600, and S&P Europe 350.
About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. With 55,000 staff across a network
of 900 laboratories in over 50 countries, Eurofins’ companies offer
a portfolio of over 200,000 analytical methods.
Eurofins Shares are listed on Euronext Paris Stock Exchange.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210909006206/en/
Investor Relations Eurofins Scientific SE E-mail:
ir@eurofins.com
Eurofins Scientific (EU:ERF)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Eurofins Scientific (EU:ERF)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024